Tris Pharma is deeply committed to patient advocacy, particularly in the areas of ADHD, pain and other CNS disorders.

We strive to improve the lives of individuals affected by these conditions through innovative drug formulations and patient-centered solutions.

We aspire to provide treatments that address the unique needs of each patient. We strive to band together with healthcare professionals (HCPs), patients and stakeholders to support patient advocacy, pursue better outcomes and advance treatments for those living with these challenging conditions.

Commitment to Patients Through Innovation

Tris recognizes and supports the unique challenges faced by patients living with ADHD and pain. Whether it’s managing the symptoms of ADHD through the day, or navigating the complexities of finding relief from pain, each patient’s journey is unique. We work tirelessly to develop medications that are tailored to the needs of those we serve.

Currently, we are pursuing the advancement of novel pain treatment options, including first-in-class therapies that align with our mission to bring transformative management solutions to patients suffering from acute, chronic and neuropathic pain. We are breaking the mold in pain biology modulation with our latest innovations in pain treatment – another way we are putting patients first to help ensure the delivery of safe, effective and high-quality medicines to the HCPs and patients we serve.

Our patient-centric approach goes beyond medications. We join forces with patients, HCPs and advocacy groups to raise awareness, educate communities and foster understanding about the impact of these conditions. We are diligent in our commitment to giving patients the support, information and resources they need to make informed decisions about their treatment and quality of life.

Mother teaching to child

ADHD

Tris Pharma is dedicated to enhancing patients’ lives for those with attention-deficit/hyperactivity disorder (ADHD) through strategic partnerships with patient advocacy groups and HCPs. By collaborating with these stakeholders, we aim to address critical challenges in ADHD and implement meaningful changes.

Partnerships with Patient Advocacy Groups
Tris actively supports patient advocacy organizations that empower the ADHD community to voice their needs and experiences, as well as provide education, support and advocacy for people with ADHD. These groups play a key role in shaping policies that enhance patients’ quality of life. Through collaboration, we affirm that the voices of ADHD patients and caregivers are heard, fostering a healthcare environment that prioritizes their needs.

Collaboration with Healthcare Professionals
Tris partners with HCPs to bridge gaps in knowledge and practice related to ADHD treatment. By engaging HCPs in educational initiatives, we aim to improve understanding, while HCPs provide insight from their experience in clinical practice and understanding of the field. This alliance enhances quality of care and helps advance the field.

Driving Change Together
Through these partnerships, Tris is committed to making a difference in the world of ADHD care and improving outcomes for patients. By leveraging the expertise of both patient advocates and HCPs, we strive to create a more comprehensive ADHD treatment landscape.

This is evident in our diverse portfolio of FDA-approved ADHD medications, including stimulant and non-stimulant options in various formulations to meet individual patient needs. Our commitment to ADHD innovation extends beyond current treatments to our robust pipeline of investigational therapies for ADHD and other neurological disorders, demonstrating our ongoing dedication to addressing patient needs in this field.

Pain

At Tris Pharma, we recognize the vital role that patients play in shaping effective pain management solutions. By partnering with patients and leveraging their personal experiences, we aim to amplify their voices while addressing their pain management challenges by revolutionizing the approach to pain treatment.

Lady having pain in joints

Patient-Centric Approach to Pain Management
Tris understands that patients and caregivers have firsthand knowledge of the emotional, physical and mental impacts of living with pain. This insight is invaluable in establishing more effective and compassionate pain management strategies. By understanding the patients’ specific journey, we aim to develop innovative solutions that address their real-world needs and challenges faced by those living with pain.

Empowering Patient Voices
Tris strives to support patient advocacy organizations that empower individuals to share their experiences and needs. These partnerships aim to:

  • Shape policies that enhance patient access to care and treatment options
  • Ensure patient voices are heard in legislative discussions
  • Foster a healthcare environment that prioritizes patient-centered care

Collaborative Research and Development
By integrating multiple perspectives into our research and development process, we are working to create pain management solutions that truly resonate with patient needs.

Youngsters Discussing

CNS Disorders

Tris is driven by a relentless loyalty to innovation which improves the lives of patients with central nervous system (CNS) disorders. We understand the profound impact these conditions have on patients, families and communities, and we are driven to improving lives through innovation, prioritization of patient needs and intentional alliances.

Partnering for Progress & Advocating for Better Outcomes

We believe that meaningful progress happens when we work together. That’s why we actively seek partnerships with patient advocacy organizations, HCPs and other key stakeholders who are passionate about improving care and outcomes for those affected by ADHD and pain. Through co-developing and collaborating on educational programs, supporting research initiatives or advocating for patients’ needs, we look forward to partnering with organizations that share our mission to make a lasting difference.

Get Involved with Tris

Are you interested in collaborating with Tris to advocate for patients living with ADHD, pain and other CNS diseases and disorders? Whether you represent an advocacy organization, an HCP or a patient support group, we would love to hear from you.

We’re eager to work jointly with third-party organizations and patient advocacy groups focused on our therapeutic areas of expertise. Together, we can work toward raising awareness and creating lasting impact for those affected by these challenging conditions.

This form is not intended for use in reporting adverse events related to Tris products. You may report such events by calling 1-732-940-0358 (U.S. only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch, where healthcare professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense or use. Visit MedWatch or call 1-800-FDA-1088.

We aim to provide treatments for ADHD, pain and other CNS disorders that address the unique needs of each patient.